Eli Lillys Orforglipron a non-peptide, oral GLP-1R agonist has demonstrated up to ~1.8% HbA1c reduction and ~12.4% body-weight loss in Phase 3 trials
Stock is always ready and samples are available on request, supporting seamless business partnerships
Chose an injection method
At Perfect B, we prioritize evidence backed options, including GLP based therapies when appropriate, metabolism supportive peptides, and muscle preserving compounds, always matched to the individual
Same-Day Appointments Available Unlike telehealth services with weeks-long wait times, we offer convenient scheduling for busy professionals, parents, ETSU students, and healthcare workers across the Tri-Cities
Our research shows there is a huge group of adults who may finally consider treatment if it comes in a pill format